dextrose inj 5% bp (1000ml pc)
luen wah medical co. sdn. bhd. - dextrose, anhydrous/anhydrous glucose -
medisol 10% none solution for infusion
2 world traders subic, inc.; distributor: 2 world traders subic, inc. - 10% dextrose in water solution for i.v. infusion - solution for infusion - none
dextrose- dextrose injection, solution
durvet - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 50 g in 100 ml - dextrose 50% is indicated for the treatment of uncomplicated ketosis in cattle. for use in animals only livestock drug
dextrose- dextrose monohydrate injection, solution
hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur. check for leaks by squeezing container firmly. if leaks are found, discard unit as sterility may be impaired. if supplemental medication is desired, follow directions below before preparing for administration. to add medication (use aseptic technique) preparation for administration (use aseptic technique) note: see appropriate i.v. administration set instructions for use. warning: do not use flexible container in series connections.
dextrose- dextrose monohydrate injection, solution
hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.
dextrose- dextrose monohydrate injection, solution
icu medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur. check for leaks by squeezing container firmly. if leaks are found, discard unit as sterility may be impaired. if supplemental medication is desired, follow directions below before preparing for administration. to add medication (use aseptic technique) preparation for administration (use aseptic technique) note: see appropriate i.v. administration set instructions for use. warning: do not use flexible container in series connections.
dextrose 50% solution- dextrose injection, solution
nova-tech, inc. - dextrose h2 o...........................50% w/v, water for injection...................q.s. - dextrose 50% solution is indicated for use as an aid in the treatment of uncomplicated primary ketosis in cattle.
elliotts b- sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodi
lukare medical, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20), anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok), magnesium sulfate, unspecified (unii: de08037sab) (magnesium cation - unii:t6v3lhy838), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb), sodium phosphat - sodium chloride 73 mg in 10 ml - elliotts b solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. none known. there is no potential for drug abuse or drug dependence.
zoladex 10.8mg
astrazeneca limited - goserelin acetate 11.34mg equivalent to 10.8 mg goserelin; - injection (depot) - 10.8 mg - active: goserelin acetate 11.34mg equivalent to 10.8 mg goserelin excipient: polyglactin - zoladex 10.8 mg is indicated for the management of: 1. prostate cancer suitable for hormonal manipulation.
2.5% travasol amino acid injection with electrolytes in 10% dextrose clinimix solution
baxter corporation clintec nutrition division - l-proline; l-tyrosine; sodium acetate; potassium phosphate dibasic; sodium chloride; magnesium chloride; tryptophan; dextrose; l-leucine hydrochloride; l-phenylalanine hydrochloride; l-lysine hydrochloride; methionine; l-alanine; glycine; l-arginine; l-isoleucine; l-valine; histidine; l-threonine - solution - 105mg; 10mg; 170mg; 130.5mg; 29.3mg; 25.5mg; 45mg; 10g; 155mg; 155mg; 145mg; 145mg; 520mg; 520mg; 260mg; 120mg; 115mg; 110mg; 10 - l-proline 105mg; l-tyrosine 10mg; sodium acetate 170mg; potassium phosphate dibasic 130.5mg; sodium chloride 29.3mg; magnesium chloride 25.5mg; tryptophan 45mg; dextrose 10g; l-leucine hydrochloride 155mg; l-phenylalanine hydrochloride 155mg; l-lysine hydrochloride 145mg; methionine 145mg; l-alanine 520mg; glycine 520mg; l-arginine 260mg; l-isoleucine 120mg; l-valine 115mg; histidine 110mg; l-threonine 105mg - caloric agents